Parkside Financial Bank & Trust Adma Biologics, Inc. Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 39 shares of ADMA stock, worth $649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 30
30.0%
Holding current value
$649
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
322Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$311 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$303 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$217 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$210 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$143 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.27B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...